SRS Capital Advisors Inc. Has $1.14 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

SRS Capital Advisors Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 102.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,812 shares of the company's stock after acquiring an additional 1,929 shares during the period. SRS Capital Advisors Inc.'s holdings in HCA Healthcare were worth $1,144,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth about $31,000. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare during the third quarter worth about $39,000. Activest Wealth Management grew its stake in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after buying an additional 125 shares during the period. Capital Performance Advisors LLP acquired a new stake in HCA Healthcare in the 3rd quarter valued at $41,000. Finally, Pinnacle Bancorp Inc. boosted its position in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on HCA. Truist Financial decreased their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a report on Monday, January 6th. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Bank of America dropped their price target on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 27th. Barclays dropped their price target on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research report on Monday, January 27th. Finally, Wells Fargo & Company lowered shares of HCA Healthcare from an "equal weight" rating to an "underweight" rating and reduced their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and an average price target of $385.67.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $4.81 during mid-day trading on Monday, reaching $311.11. The company had a trading volume of 1,413,615 shares, compared to its average volume of 1,731,940. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The stock has a market cap of $77.26 billion, a PE ratio of 14.16, a P/E/G ratio of 1.10 and a beta of 1.64. The company has a 50-day moving average price of $315.15 and a two-hundred day moving average price of $349.23.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business earned $5.90 earnings per share. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.93%. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio (DPR) is 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.